ScreenerHero

CELU Celularity Inc.

NAS · US · Healthcare · Biotechnology · celularity.com
1.470USD-6.96%Mkt Cap: 47.70M $P/E: —

Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBa…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap47.70M USD
Enterprise Value118.98M USD
Revenue (TTM)18.97M USD
Gross Profit6.48M USD
Net Income (TTM)-91.72M USD
Revenue/Share0.70 USD
Last Price1.470 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees115
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.77
PEG—
EV/EBITDA-2.21
EV/Revenue6.27
P/S2.70
P/B-1.31
EPS (TTM)-2.73
EPS (Forward)-0.57
52W Range
0.560151% of range2.350
52W High2.350 USD
52W Low0.5601 USD
Profitability
Gross Margin24.39%
Oper. Margin-263.47%
EBITDA Margin-284.12%
Profit Margin-345.45%
ROE240.96%
ROA-85.45%
Growth
Revenue Growth-66.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.25M USD
CapEx (TTM)—
FCF Margin-7.17%
FCF Yield-2.85%
Net Debt67.71M USD
Net Debt/EBITDA-1.26
Balance Sheet
Debt/Equity-1.07
Current Ratio0.09
Quick Ratio0.07
Book Value/Sh-1.21 USD
Cash/Share0.01 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateFeb 29, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.32.45M
Float22.37M
Insiders33.17%
Institutions11.49%
Short Interest
Short Ratio0.1d
Short % Float12.32%
Short % Out.2.84%
Shares Short821.02K
Short (prev mo.)403.57K
Technical
SMA 501.137 (+29.2%)
SMA 2001.095 (+34.3%)
Beta0.78
S&P 52W Chg16.45%
Avg Vol (30d)721.57K
Avg Vol (10d)169.62K
Technical Indicators
RSI (14)55.9
MACD0.1097
MACD Signal0.1062
MACD Hist.+0.0035
BB Upper1.677 USD
BB Middle1.395 USD
BB Lower1.114 USD
BB Width40.34%
ATR (14)0.1520 USD
Vol Ratio (20d)0.37x